The RNA-guided clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 system has been used recently to correct HBB mutation in iPSCs derived from β-thalassemia [8–11] and sickle cell disease patients [12]. Here, HBB is linked to sickle cell disease.